Remedy Entertainment Oyj - Decisions of general meeting

Remedy Entertainment Plc: Resolutions of Remedy Entertainment Plc's Annual General Meeting and the organizing meeting of the Board of Directors

Remedy Entertainment Plc      Stock Exchange Release      April 12, 2024, 1 p.m.
(EEST)

Resolutions of Remedy Entertainment Plc's Annual General Meeting and the
organizing meeting of the Board of Directors

The Annual General Meeting of Remedy Entertainment Plc was held on April 12,
2024 at the company's office at Luomanportti 3, 02200 Espoo, Finland.
Shareholders were also able to exercise their voting rights by voting in advance
and it was possible to follow the Annual General Meeting through a live
webstream.

The Annual General Meeting adopted the Financial Statements for 2023, discharged
the members of the Board of Directors and the CEO from liability, adopted the
company's Remuneration Report and approved all proposals made to the Annual
General Meeting in the form included in the notice to the Annual General
Meeting.

Resolution on the use of the profit shown on balance sheet and dividend
distribution

The Annual General Meeting resolved that no dividends shall be distributed for
the financial period ended on December 31, 2023.

Composition and remuneration of the Board of Directors

The Annual General Meeting resolved that the number of Board members shall be
five. Markus Mäki, Kaisa Salakka, Sonja Ängeslevä, Henri Österlund and Kai
Tavakka were elected to the Board of Directors.

The Annual General Meeting resolved that the remuneration of the Board of
Directors will remain unchanged. The Chairman of the Board of Directors is paid
EUR 4500 per month and each of the other members of the Board of Directors are
paid EUR 3000 per month.

Election and remuneration of the Auditor

The Annual General Meeting resolved to re-elect audit firm KPMG Oy Ab as the
company's Auditor. Petri Sammalisto, APA, will continue as the company's
principally responsible auditor.

The Annual General Meeting resolved that the Auditor's fees will be paid against
the Auditor's reasonable invoice to be approved by the company.

Authorising the Board of Directors to resolve on the repurchase of own shares

The Annual General Meeting granted the Board of Directors an authorisation to
resolve on the repurchase of Remedy Entertainment Plc's own shares (treasury
shares) in one or several instalments with the following terms:

By virtue of the authorisation, the Board of Directors can resolve on the
repurchase of a total maximum of 700,000 treasury shares by using the company's
non-restricted equity. The proposed maximum number of shares that can be
repurchased equals to approximately 5.20 percent of the company's all shares at
the publication date of this release.

Treasury shares are repurchased otherwise than in proportion to the existing
shareholdings of the company's shareholders in public trading at the market
price quoted at the time of purchase. Treasury shares are repurchased and paid
pursuant to the rules of Euroclear Finland Oy and conducted in accordance with
the Market Abuse Regulations (EU) N:o 596/2014. The Board of Directors has the
authority to decide on all other matters pertaining to the repurchase of
treasury shares.

The authorisation is valid until the close of the company's following Annual
General Meeting, but no longer than 18 months from the date of the Annual
General Meeting's resolution. The authorisation replaces the share repurchase
authorisation given to the Board of Directors by the company's Annual General
Meeting held on April 13, 2023.

Authorising the Board of Directors to resolve on the issuances of shares and
special rights to shares

The Annual General Meeting granted the Board of Directors an authorisation to
resolve on the issuance of new shares, treasury shares and special rights to
shares in one or several instalments with the following terms:

By virtue of the authorisation, the Board of Directors can resolve on the
issuance of a maximum total of 700,000 new shares or treasury shares held by the
company either against payment or without payment. The proposed maximum number
of shares equals to approximately 5.20 percent of the company's all shares at
the publication date of this release. The Board of Directors is also entitled to
resolve on the issuance of option rights and other special rights to shares
referred to in Chapter 10, Section 1 of the Finnish Companies Act either against
payment or without payment within the maximum number of shares referred to
above.

The new shares, treasury shares held by the company and special rights to shares
may also be issued in deviation from shareholders' pre-emptive subscription
right in a directed issuance if there is a weighty financial reason for doing so
from the company's point of view. The Board of Directors has the authority to
decide on all other matters pertaining to the issuances of shares and special
rights to shares.

The authorisation is valid until the close of the company's following Annual
General Meeting, but no longer than 18 months from the date of the Annual
General Meeting's resolution. The authorisation replaces the previous
authorisation to resolve on the issuance of shares and special rights entitling
to shares which was given to the Board of Directors by the company's Annual
General Meeting held on April 13, 2023.

Minutes of the Annual General Meeting

The Annual General Meeting minutes will be available at the latest by April 26,
2024, on the company's website at https://investors.remedygames.com/annual
-general-meeting-2024/.

Organizing meeting of the Board of Directors

At its organizing meeting held after the Annual General Meeting, the Board of
Directors elected Markus Mäki to continue as the Chairman of the Board of
Directors.


More information

Liisa Eloranta, Senior IR Specialist
Phone: +358504334992

Email: liisa.eloranta@remedygames.com (liisa.eloranta@remedygames.com)

  About Remedy

Remedy Entertainment Plc is a pioneering, globally renowned video game company
founded in 1995 and headquartered in Finland with an office in Stockholm,
Sweden. Known for its story-driven and visually stunning action games, Remedy
has created multiple successful, critically acclaimed franchises such as
Control, Alan Wake and Max Payne. Remedy also develops its own Northlight game
engine and tools technology that powers many of its games.

www.remedygames.com